— What’s your move? Read on.
- When is reperfusion therapy appropriate?
- Antiplatelet or anticoagulation—and for how long?
When to Think of It
Sick or Not Sick
The First Fifteen Minutes
- ABCs, bedside glucose, cardiac monitor, two IVs, frequent neurologic reassessment, and last-known-well time.
- Suspected acute ischemic stroke with disabling deficit and no hemorrhage/contraindication → tenecteplase 0.25 mg/kg IV push, maximum 25 mg within the accepted treatment window, or alteplase 0.9 mg/kg IV (maximum 90 mg; 10% bolus, remainder over 60 minutes) per local stroke protocol. Fibrinolysis restores flow before irreversible infarction; verify dosing with institutional stroke protocol.
- Large-vessel occlusion on CTA → immediate neurointerventional consultation for mechanical thrombectomy; do not delay transfer for additional testing.
- Blood pressure above 185/110 mm Hg when thrombolysis is planned → labetalol 10–20 mg IV over 1–2 minutes, repeat once, or nicardipine 5 mg/h IV infusion, titrating by 2.5 mg/h every 5–15 minutes, maximum 15 mg/h. Lowering pressure permits safer thrombolysis.
- No thrombolysis and BP below 220/120 mm Hg → generally avoid acute BP reduction, because cerebral perfusion may be pressure-dependent.
- Confirmed ischemic stroke without thrombolysis and hemorrhage excluded → aspirin 325 mg PO or rectally once; it reduces early recurrent embolic events. Do not give antiplatelet therapy before excluding intracranial hemorrhage.
Definitive Care & Disposition
How This One Kills
- Migraine with aura — stereotyped positive symptoms and gradual spread; confusing it with dissection delays vascular imaging and stroke treatment.
- Carotid sinus or cervical muscle injury — local pain without retinal or focal neurologic ischemia; missing dissection risks embolization.
- Subarachnoid hemorrhage — thunderclap headache, meningismus, or reduced consciousness; treating presumed dissection without hemorrhage exclusion can worsen bleeding.
- Cerebral venous thrombosis — headache with seizures, papilledema, or diffuse deficits; the vascular territory and treatment strategy differ.
The Second-Day Story
Study Directive
- Draw the carotid and vertebral dissection presentations from memory, including Horner syndrome and posterior-circulation symptoms.
- Review your institutional thrombolysis and thrombectomy inclusion/exclusion criteria.
- Practice a 60-second stroke activation presentation using last-known-well, deficit, glucose, BP, and anticoagulant status.
- Complete five cases distinguishing migraine, dissection, subarachnoid hemorrhage, and cerebral venous thrombosis.
Recent Literature
-
Review or guideline Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association
The AHA statement provides a practical reference for recognition, vascular imaging, acute reperfusion eligibility, and individualized antithrombotic therapy for cervical artery dissection.
-
Recent clinical Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study
STOP-CAD found no clear overall stroke-prevention advantage with anticoagulation over antiplatelet therapy, while prolonged anticoagulation increased major bleeding, supporting individualized agent choice and duration.